The custom antibody market is poised for significant growth, projected to escalate from USD 579 million in 2024 to USD 901 million in 2029, boasting a robust CAGR of 9.2% during the forecast period. Driving factors include escalating demand for personalized medicines, a global upsurge in chronic diseases, and strides in genetic engineering. Dominated by key players like Thermo Fisher...